Peli Continues Enhancement of Cold Chain Industry
News Apr 23, 2013
Peli Products, Inc. has announced the acquisition of Minnesota Thermal Science (MTS), the industry leader in global temperature controlled transportation products.
Based in Plymouth, Minnesota, MTS will merge with Peli’s already established BioPharma™ division.
“The combined entity will offer customers an even wider range of the most advanced temperature controlled packaging solutions for the safe transport of pharmaceuticals, tissue, biologics, diagnostics, blood and other healthcare products,” said Lyndon Faulkner, President and CEO of Peli.
Faulkner continued, “The award-winning thermal protection products of MTS will be matched with Peli’s global capabilities providing a worldwide solution of re-usable transportation and packaging products and services.”
In addition to Peli BioPharma cases that offer 140+ hours between 2.0 to 8.0C, customers will have access to the full suite of MTS products including the reusable Credo Cube®, which protects payload contents at defined temperatures longer than any other passive thermal shipper.
Equally impressive are the Credo Xtreme® full pallet which holds 890 litres and the half pallet which holds 406 litres, each providing 35 percent more payload space than the closest competitor.
In addition to their unique scientific packaging, MTS offers a complete range of services and software to support a reusable temperature controlled packaging solution.
“Joining forces with Peli will enable us to aim even higher and provide customers with an unmatched global cold chain solution under one company”, said Tom Anderson, CEO of MTS.
Anderson continued, “We’re confident that together we’ll deliver products and services to the industry better than any competitive offering. An accelerated product development programme which will significantly enhance the combined company’s solution set and associated cold chain services is already underway.”
Identify Bacteria Quickly and Accurately Using Artificial IntelligenceNews
Microscopes enhanced with artificial intelligence (AI) could help clinical microbiologists diagnose potentially deadly blood infections and improve patients’ odds of survival, according to microbiologists at Beth Israel Deaconess Medical Center (BIDMC).READ MORE
New Rapid Test for Valley Fever Should Help Reduce Diagnosis DelaysNews
November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.READ MORE
Blood Sample Detection Method for Multiple Sclerosis DiscoveredNews
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spineREAD MORE